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Background: Aluminum is used in a wide range of applications and is a potential environmental hazard. The
known genotoxic effects of aluminum might play a role in the development of breast cancer. However, the data
currently available on the subject are not sufficient to establish a causal relationship between aluminum exposure
and the augmented risk of developing breast cancer. To achieve maximum sensitivity and specificity in the
determination of aluminum levels, we have developed a detection protocol using graphite furnace atomic
absorption spectrometry (GFAAS). The objective of the present study was to compare the aluminum levels in the
central and peripheral areas of breast carcinomas with those in the adjacent normal breast tissues, and to identify
patient and/or tumor characteristics associated with these aluminum levels.
Methods: A total of 176 patients with breast cancer were included in the study. Samples from the central and
peripheral areas of their tumors were obtained, as well as from the surrounding normal breast tissue. Aluminum
quantification was performed using GFAAS.
Results: The average (mean ± SD) aluminum concentrations were as follows: central area, 1.88 ± 3.60 mg/kg;
peripheral area, 2.10 ± 5.67 mg/kg; and normal area, 1.68 ± 11.1 mg/kg. Overall and two-by-two comparisons of the
aluminum concentrations in these areas indicated no significant differences. We detected a positive relationship
between aluminum levels in the peripheral areas of the tumors, age and menopausal status of the patients (P = .02).
Conclusions: Using a sensitive quantification technique we detected similar aluminum concentrations in the
central and peripheral regions of breast tumors, and in normal tissues. In addition, we did not detect significant
differences in aluminum concentrations as related to the location of the breast tumor within the breast, or to other
relevant tumor features such as stage, size and steroid receptor status. The next logical step is the assessment of
whether the aluminum concentration is related to the key genomic abnormalities associated with breast carcinogenesis.
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The use of aluminum, in many different chemical pre-
sentations, has now reached the highest level in docu-
mented history. This element is one of the most
common metals in the lithosphere, and it is utilized in a
wide range of industries manufacturing products such as
food, paper, dyes, pigments, paints, glass, fuels, textiles,* Correspondence: sarian@unicamp.br
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distribution, and reproduction in any mediumcosmetics and pharmaceuticals; it is also used in water
purification and oil refining processes. The presence of
elevated concentrations of aluminum in the general pub-
lic might be a consequence of its extensive use [1].
It has been hypothesized that powerful antiperspirants
containing aluminum compounds, widely used in current
formulations of hygiene products that are generally applied
to the axilla, may pose some risks to health [2]. Recent evi-
dence has indicated increased genomic instability in the
outer quadrants of the breast [3], and in one report it was
suggested that higher levels of aluminum may be presentCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Diagram showing the locations of the tissue samples
obtained from each subject. Surgical specimens and lesion
dimensions vary from subject to subject. *Resection margins apply
to conservative surgeries (quadrantectomies). For patients treated
with radical mastectomy, the resection margins are the boundaries
of the resected organ.
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regions (medial and middle) [4]. Besides being associated
with carcinogenic effects in animal studies, aluminum is
known to bind to DNA and to be genotoxic. The metal
also exhibits neuronal effects in humans, showing an influ-
ence on iron homeostasis, which might link aluminum
chronic exposure with the development of Parkinson’s and
Alzheimer’s diseases [5,6]. Also, a few types of metal such
as aluminum, cadmium, mercury, copper, cobalt, among
others, have the capacity to bind to the estrogen receptors
in cells and mimic the function of this hormone, although
other studies have refuted this idea [7-9]. Even though they
have different and complex structures, some of these
metals were described as having the ability to bind to estro-
gen receptors in the majority of tumor cell lines tested,
both in vitro and in vivo; this mechanism might lead to al-
tered protein expression, mammary gland development
and precocious puberty, and can increase the height of the
uterus and influence androgen response [7].
The current data regarding elevated levels of aluminum
in some areas of the breast, and the known biological ef-
fects of this metal in breast tissues, are not sufficient to
establish a causal relationship between aluminum expos-
ure and the augmented risk of developing breast cancer.
Studies addressing this issue differ in relation to the tech-
niques used to detect and quantify the aluminum levels.
High specificity techniques, formerly used in non-
biological experiments, have now been standardized for
metal level determinations in biological samples [10-12].
Atomic Absorption Spectrometry (AAS) has been used
to accurately determine the metal concentrations in hu-
man breast tissues [4]. In one study using this technique,
significantly higher levels of a few heavy metals were
detected in the blood and tissues of women with breast
lesions relative to healthy controls [13].
We have developed an aluminum detection protocol,
tailored for breast tissues, using graphite furnace-AAS
(GFAAS) to achieve maximum sensitivity and specificity
in the determination of aluminum levels. In the present
study, we thus contrasted the aluminum levels of central
and peripheral areas of breast carcinomas and the adja-
cent normal breast tissues in an unprecedentedly large
set of patients. We also tried to identify patient and/or
tumor characteristics that were possibly associated with
aluminum levels.
Methods
Patients and sample collection
For this cross-sectional study, we recruited a total of
176 women who had consecutively undergone surgical
(either radical or conservative) treatment for breast can-
cer at the Breast Cancer Clinics of the Women’s Hospital
Prof. Dr. José Aristodemo Pinotti - CAISM, at the State
University of Campinas (UNICAMP), between 2008 and2010. Immediately after the removal of the surgical speci-
men one of the researchers macroscopically assessed the
specimen, identified and measured the tumor area. Next,
if the tumor area had a great axis that was larger than
1.0 cm, the researcher sampled the central and the per-
ipheral regions of the tumor with a scalp, and divided
each of the two samples into two mirror fragments. Also,
a sample from a macroscopically normal glandular area
of the breast was obtained, and the sample was divided
into two mirrored fragments (Figure 1). One of the two
fragments from the central and peripheral tumor areas,
as well as from the normal glandular area, were stored
at −196°C for further measurements of aluminum con-
centration, and the other fragment was fixed in forma-
lin for subsequent embedding in paraffin. The fragment
sent for paraffin embedment was processed and stained
using H&E, and subsequently assessed by an experi-
enced pathologist who determined the presence of inva-
sive carcinomas in the sample. The mirror fragments of
the selected specimens were sent for aluminum quanti-
fication. Twenty-six women had to be excluded from
this study due to technical difficulties or the absence of
invasive breast carcinoma in the collected fragment.
Thus, 150 viable samples were obtained for the study.
Clinicopathological data were obtained from patient re-
cords. The study protocol was fully approved by the Re-
search Ethics Committee of the Faculty of Medical
Sciences - State University of Campinas (CEP #705/
2007) and all patients signed informed consent forms.
Aluminum quantification using GFAAS
Evaluation of tissue aluminum content was carried out
at the Chemistry Institute of the Campinas State Univer-
sity (IQ/UNICAMP). The previously frozen tissue sam-
ples (−196°C) from the central and peripheral areas of
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sue, were dried in Falcon tubes in a vacuum desiccator
at low pressure for 60 h. These tubes were weighed be-
fore and after tissue drying, for estimation of the wet
mass. After drying, the tubes containing the samples
were weighed to determine the dry tissue mass. This en-
abled standardization of the amount of tissue used in
each case, thus removing the interference from water
content. All of the glassware used in the analysis was
previously treated with 10% v/v concentrated HNO3
and then washed three times with ultrapure water.
Sample solubilization was carried out overnight using
25% (m/v) tetramethylammonium hydroxide (TMAH),
in the proportion of 1 ml of reagent to 250 mg of wet
sample [14]. After solubilization, the samples were di-
luted with an aqueous solution of 0.35% Triton-X 100
to a final volume corresponding to a dilution factor of
75 times; this was prepared with ultrapure water for
stabilization of the fat/water system, and the samples
were analyzed using GFAAS.
The measurements were carried out using the fol-
lowing: a GFAAS (AAnalyst model 600, Perkin-Elmer,
Norwalk, CT, USA) with background correction based
on the Zeeman effect; an automatic sampler (model
AS-800, Perkin-Elmer, Norwalk, CT, USA); and THGA
graphite tubes with an integrated L’vov platform and
transversal heating (Perkin-Elmer). An aluminum hol-
low cathode lamp (λ = 309.271 nm; I = 25 mA) was
used, and the measurements were made in integrated
absorbance units. The volumes of the sample and the
chemical modifier, Mg(NO3)2, were 20 μL and 5 μL, re-
spectively. External calibration standards of aluminum
containing 1.3% TMAH solution (v/v), which comprised
aluminum concentrations from 2–24 μg/kg, were used
under the optimized instrumental conditions for the
heating program shown in Table 1. The samples ana-
lyzed were fat-rich and this is undesirable in order toTable 1 Optimized heating program for GF AAS
measurements
Step Temperature Ramp Time Hold time Flow rate
(°C) (s) (s) (mL min− 1)
Drying 110 1 30 250
Drying 130 15 30 250
Pyrolysis 1500 10 20 250
Atomization 2350 0 5 0
Cleaning 2450 1 3 250
Cooling 20 1 5 250
Note: Correlation coefficients for Aluminum concentration and the water
content of the samples were: 0.23 for normal tissues; 0.26 for peripheral tumor
areas, and 0.16 for peripheral tumor areas, showing that samples with
increased water content (and therefore lower fat content) had slightly higher
concentrations of aluminum.have quantitative recovery of aluminum during GFAAS
measurements. In this case, an alkaline treatment with
TMAH [14] allowed the complete solubilization of the
samples. Additionally, the use of (Mg(NO3)2) as chemical
modifier for the GFAAS heating program showed to be
mandatory to obtain quantitative recoveries of the ana-
lyte. The correlation coefficients (R) for aluminum con-
centration and the water content of the samples were:
0.23 for normal tissues; 0.26 for peripheral tumor areas,
and 0.16 for peripheral tumor areas, showing that sam-
ples with increased water content (and therefore lower
fat content) had slightly higher concentrations of
aluminum (Table 1). Analytical curves with correlation
coefficient values lower than 0.995 were not accepted.
Samples were divided into five smaller groups for ana-
lysis; for each group two reagent blanks were prepared,
ensuring that the contamination originating from re-
agents and from the laboratory environment was mini-
mized. Aluminum measurements were displayed in
mg/kg. All of the measurements were made in triplicate.
Analytical curve plots and calculation of aluminum con-
centration were carried out using ORIGIN PRO 7.0 soft-
ware. To verify the accuracy of the proposed method,
experiments involving the addition and recovery of the
analyte were conducted, showing values between 96
and 111%.
Statistical analysis
Data were stored in ExcelW spreadsheets and analyzed
using the R Environment for Statistical Computing [15].
Confidence levels were set at 95% (P < .05 was consid-
ered significant). As a first step, we tested whether
aluminum concentrations in the three regions (central
and peripheral tumor regions, and normal breast tis-
sues) conformed to the assumption of normality using
the Shapiro-Wilk test. Log-transformed (to base e)
values were used, since the raw data showed marked
skewness. Results are presented in the original scale.
After ascertaining data compliance to normality, we
used the pairwise t-test for the comparison of the
aluminum concentration in the central, peripheral and
normal areas of the tumors. Paired comparisons were
used in the calculations regarding data from central,
peripheral and normal tissue samples obtained from the
same individual. Next, we assessed the relationship be-
tween the clinical and pathological features of the cases
and the aluminum concentration in the central, periph-
eral and normal areas (Tables 2, 3 and 4). For these
analyses, we first examined the distribution of the
aluminum concentration in the whole set of samples,
considering the tissue’s dry and defatted mass. We
compared the mean aluminum concentration in relation
to the clinical and pathological features of the patients
and tumors (age, body mass index, menopausal status,
Table 2 Aluminum content in central areas of the tumor according to the clinical characteristics of the women and the
pathological features of the tumors
Characteristics Total Aluminum content in mg/Kg
Mean (sd) Negative* 0.05 - 2.0 ≥ 2
Age P** n (%) n (%) n (%) P trend***
<40 20 1.25(1.49) 0.12 6 (17.6) 9 (11.1) 5 (14.3) 0.68
>40 130 1.97(3.81) 28 (82.4) 72 (88.9) 30 (85.7)
BMI
<25 46 1.96(2.43) 0.74 7 (28) 26 (38.2) 13 (40.6) 0.34
≥25 79 2.05(4.39) 18 (72) 42 (61.8) 19 (59.4)
Menopausal status
Post 42 1.28(1.32) 0.03 9 (33.3) 23 (32.9) 10 (29.4) 0.73
Pre 89 2.34(4.40) 18 (66.7) 47 (67.1) 24 (70.6)
Quadrant
Upper external 92 1.83(3.61) 0.93 23 (67.6) 47 (58) 22 (62.9) 0.69
Other 58 1.94(3.61) 11 (32.4) 34 (42) 13 (37.1)
Tumor size
<2.0 cm 72 2.36(4.64) 0.21 13 (38.2) 39 (49.4) 20 (57.1) 0.11
≥2.0 cm 76 1.44(2.21) 21 (61.8) 40 (50.6) 15 (42.9)
Stage
I-II 90 2.19(4.37) 0.13 19 (57.6) 49 (61.3) 22 (62.9) 0.65
III – IV 58 1.42(1.90) 14 (42.4) 31 (38.8) 13 (37.1)
Histologic grade
I-II 26 2.36(6.02) 0.79 5 (15.6) 17 (23) 4 (12.1) 0.70
III 113 1.74(2.87) 27 (84.4) 57 (77) 29 (87.9)
Estrogen receptor
Negative 40 1.34(1.48) 0.67 12 (36.4) 17 (22.4) 11 (32.4) 0.72
Positive 103 2.13(4.22) 21 (63.6) 59 (77.6) 23 (67.6)
Progesterone receptor
Negative 56 1.34(1.31) 0.86 15 (45.5) 28 (36.8) 13 (39.4) 0.61
Positive 86 2.25(4.59) 18 (54.5) 48 (63.2) 20 (60.6)
cerbb2 status
Negative 94 1.91(3.54) 0.18 22 (66.7) 47 (63.5) 25 (75.8) 0.43
Positive 46 1.91(4.07) 11 (33.3) 27 (36.5) 8 (24.2)
Note: The aluminum concentration was categorized as negative, 0.05-2.0 mg/ kg and ≥ 2.0 mg/ kg according to the three-tiered percentile distribution of the raw
data. *Aluminum detection threshold for the GF-AAS was set at 0.05 mg/kg; ** In this column, the p values refer to the comparison of the mean Aluminum
concentrations in each strata, using independent samples t-tests with the log-transformed (to base e) data; ***In this column, the p-values refer to the Chi-squares
for trends; i.e. if p ≤ 0.05, there is a significant trend in Aluminum concentration related to the specified characteristic (see statistics for more details).
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histological grade, estrogen/progesterone receptor and
cerbb2 statuses) using a linear regression model, for
which we used log-transformed (to base e) data. We
next determined three aluminum concentration groups
based on the approximate three-tiered percentile distri-
bution of the data: negative (null aluminum readings);
0.05-2.0 mg/kg; and ≥ 2.0 mg/kg. Finally, we tested
whether the clinical and pathological features of the pa-
tients and tumors features were associated with the trendin aluminum concentration using the chi-squared propor-
tion trend test.
Results
Table 5 shows the aluminum concentration per tumor re-
gion, taking into consideration the central and peripheral
regions of the tumor and normal breast tissue. The average
aluminum content was 1.88 mg/kg in the central areas,
2.10 mg/ kg in the peripheral areas and 1.68 mg/ kg in the
normal areas. Overall and two-by-two comparisons of the
Table 3 Aluminum content in peripheral areas of the tumor according to the clinical characteristics of the women and
the pathological features of the tumors
Characteristics Total Aluminum content in mg/Kg
Mean (sd) Negative* 0.05 - 2.0 ≥ 2
Age P** n (%) n (%) n (%) P trend***
<40 20 1.71(1.79) 0.02 4 (16) 9 (10) 7 (20) 0.52
>40 130 1.97(3.81) 21 (84) 81 (90) 28 (80)
BMI
<25 46 2.13(1.06) 0.87 5 (31.2) 28 (36.8) 13 (39.4) 0.59
≥25 79 2.34(1.93) 11 (68.8) 48 (63.2) 20 (60.6)
Menopausal status
Post 42 2.09(2.33) 0.02 6 (35.3) 22 (27.8) 14 (40) 0.49
Pre 89 2.47(1.15) 11 (64.7) 57 (72.2) 21 (60)
Quadrant
Upper external 92 1.96(3.57) 0.86 14 (56) 56 (62.2) 22 (62.9) 0.61
Other 58 2.33(1.97) 11 (44) 34 (37.8) 13 (37.1)
Tumor size
<2.0 cm 72 2.31(7.23) 0.81 12 (48) 40 (44.9) 20 (58.8) 0.34
≥2.0 cm 76 1.92(3.77) 13 (52) 49 (55.1) 14 (41.2)
Stage
I-II 90 1.76(3.23) 0.48 13 (52) 56 (63.6) 21 (60) 0.61
III – IV 58 2.67(2.19) 12 (48) 32 (36.4) 14 (40)
Histologic grade
I-II 26 1.28(1.17) 0.83 5 (21.7) 16 (19.3) 5 (15.2) 0.52
III 113 2.40(2.48) 18 (78.3) 67 (80.7) 28 (84.8)
Estrogen receptor
Negative 40 1.77(1.57) 0.19 5 (21.7) 22 (25.6) 13 (38.2) 0.14
Positive 103 2.32(2.76) 18 (78.3) 64 (74.4) 21 (61.8)
Progesterone receptor
Negative 56 1.94(2.56) 0.15 7 (30.4) 32 (37.6) 17 (50) 0.12
Positive 86 2.31(7.20) 16 (69.6) 53 (62.4) 17 (50)
cerbb2 status
Negative 94 1.91(3.54) 0.09 17 (73.9) 52 (62.7) 25 (73.5) 0.86
Positive 46 1.91(4.07) 6 (26.1) 31 (37.3) 9 (26.5)
Note: The aluminum concentration was categorized as negative, 0.05-2.0 mg/ kg and ≥ 2.0 mg/ kg according to the three-tiered percentile distribution of the raw
data. *Aluminum detection threshold for the GF-AAS was set at 0.05 mg/kg; ** In this column, the p values refer to the comparison of the mean Aluminum
concentrations in each strata, using independent samples t-tests with the log-transformed (to base e) data; ***In this column, the p-values refer to the Chi-squares
for trends; i.e. if p ≤ 0.05, there is a significant trend in Aluminum concentration related to the specified characteristic (see statistics for more details).
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nificant differences. The average aluminum content in
tumor areas (either central or peripheral) was not signifi-
cantly different from that in normal tissues.
The average aluminum concentration in each area was an-
alyzed according to the key clinical features and pathological
characteristics of the cases (Tables 2, 3 and 4). We detected
a positive relationship between aluminum levels in the per-
ipheral areas of the tumors, age and menopausal status of
the patients (P= .02 in each case) and in the central areasfor menopausal status (p=.03). We also detected a positive
relationship between estrogen and progesterone receptor
expression and aluminum levels in the normal tissues (p =
0.009 and 0.04, respectively). The other comparisons did not
yield any significant results. Next, the aluminum content
was categorized into three levels (negative, 0.05-2.0 mg/kg
and > 2.0 mg/kg), respecting the three-tiered percentile
distribution of aluminum concentration in the whole. No
significant trends in patient or tumor characteristics were
found as related to the aluminum concentrations.
Table 4 Aluminum content in normal areas of the breast according to the clinical characteristics of the women and the
pathological features of the surrounding tumors
Characteristics Total Aluminum content in mg/Kg
Mean (sd) Negative* 0.05 - 2.0 ≥ 2
Age P** n (%) n (%) n (%) P trend***
<40 20 1.13(1.59) 0.17 3 (14.3) 15 (12.8) 2 (16.7) 0.91
>40 130 1.76(11.90) 18 (85.7) 102 (87.2) 10 (83.3)
BMI
<25 46 3.68(19.9) 0.38 5 (33.3) 36 (35.6) 5 (55.6) 0.40
≥25 79 0.78(1.13) 10 (66.7) 65 (64.4) 4 (44.4)
Menopausal status
Post 42 4.06(20.88) 0.12 6 (35.3) 33 (31.7) 3 (30) 0.75
Pre 89 0.73(0.98) 11 (64.7) 71 (68.3) 7 (70)
Quadrant
Upper external 92 2.19(14.13) 0.59 15 (71.4) 70 (59.8) 7 (58.3) 0.37
Other 58 0.87(1.32) 6 (28.6) 47 (40.2) 5 (41.7)
Tumor size
<2.0 cm 72 0.78(0.94) 0.28 6 (30) 60 (51.7) 6 (50) 0.16
≥2.0 cm 76 2.56(15.56) 14 (70) 56 (48.3) 6 (50)
Stage
I-II 90 2.19(14.28) 0.42 10 (50) 74 (63.8) 6 (50) 0.75
III – IV 58 0.92(1.51) 10 (50) 42 (36.2) 6 (50)
Histologic grade
I-II 26 0.89(1.30) 0.53 4 (21.1) 20 (18.2) 2 (20) 0.88
III 113 1.89(12.75) 15 (78.9) 90 (81.8) 8 (80)
Estrogen receptor
Negative 40 0.56(0.49) 0.009 2 10 37 33.3 1 (8.3) 0.62
Positive 103 2.18(13.37) 18 90 74 66.7 11 (91.7)
Progesterone receptor
Negative 56 0.63(0.68) 0.04 4 (20) 49 (44.5 3 (25) 0.43
Positive 86 2.46(14.62) 16 (80) 61 (55.5) 9 (75)
cerbb2 status
Negative 94 0.82(1.19) 0.77 13 (68.4) 74 (67.9) 7 (58.3) 0.61
Positive 46 3.68(19.96) 6 (31.6) 35 (32.1) 5 (41.7)
Note: The aluminum concentration was categorized as negative, 0.05-2.0 mg/ kg and ≥ 2.0 mg/ kg according to the three-tiered percentile distribution of the raw
data. *Aluminum detection threshold for the GF-AAS was set at 0.05 mg/kg; ** In this column, the p values refer to the comparison of the mean Aluminum
concentrations in each strata, using independent samples t-tests with the log-transformed (to base e) data; ***In this column, the p-values refer to the Chi-squares
for trends; i.e. if p ≤ 0.05, there is a significant trend in Aluminum concentration related to the specified characteristic (see statistics for more details).
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In our study, using a high-specificity technique, we
detected similar aluminum concentrations in the cen-
tral and peripheral regions of breast tumors. More
interestingly, these concentrations did not depart
from the aluminum levels found in the surrounding
normal tissues. The results clearly suggest that there
is no aluminum gradient from normal to diseased
breast tissue. Our study also examined whether tumor
location within the breast, among other variables,influenced the aluminum concentrations; results were
negative.
The relationship between aluminum exposure and
breast cancer has been hypothesized for a long time.
However, there are technical challenges involved in
measuring the metal content of human tissues. This
is especially true for breast tissues which contain a
high content of fat, which makes sample preparation
difficult. Early studies used indirect measurements of
the aluminum content of breast tissues, for example
Table 5 Comparison of Aluminum concentration in central
and peripheral regions of the tumors, and normal breast
tissue
Aluminum concentration per tumor region (mg/kg)
Central Peripheral Normal
Mean 1.88 2.10 1.68 p-value*




Mean 1.99 1.68 p-value*
Standard deviation 3.46 11.1 0.74
Two-by-two comparisons





*Paired t-tests were used to evaluate the within-individual variations in
Aluminum concentrations. Log-transformed (to base e) data were used (see
statistics section) in order to conform to normality.
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containing aluminum [16,17]. More recent studies
have used better performing direct measurement
techniques [18,19]. Even minimal differences in
aluminum concentration may be of biological signifi-
cance, since in vitro studies regarding the effects of
aluminum and other metals on the cell have demon-
strated that even concentrations as low as 4 nmol/g
may exert proestrogenic and possibly carcinogenic ef-
fects [4]. Our study was a specificity-driven attempt
at quantifying the aluminum content of the human
breast, and featured one of the larger sample sizes of
diseased and normal breast tissues. Pasha et al. [19]
compared malignant and benign breast lesions (nor-
mal breast tissue was not examined) in a set of 114
lesions, and found no difference in aluminum con-
centration between benign and malignant lesions. In
another study [4], the aluminum content was measured in
tissue samples from the axilla, lateral, middle and medial
regions of the breast of 17 patients who underwent mast-
ectomy due to breast cancer. These authors reported a sig-
nificantly higher aluminum concentration in the outer
(axilla plus lateral regions) relative to the inner (middle
and medial regions) breast. By way of contrast, the
aluminum concentration did not differ across breast quad-
rants in our study. However, it is worth mentioning that it
was designed to evaluate differences in aluminum concen-
trations between central and peripheral areas of breast tu-
mors, but not to assess the differences in aluminum
concentrations across breast quadrants.
As compared with other studies, we detected lower
aluminum concentrations in breast cancer tissues and
normal breast samples. Differences related to samplecollection and processing might have accounted for the
different results. While a majority of studies have
reported mean values of aluminum for both normal and
cancerous tissues in the range 3.63-19.5 μg/g [18-20],
our results showed values of 1.68 μg/g for normal breast
specimens and 1.88-2.1 μg/g for breast cancer specimens
(when converted to the same unit of measurement).
We detected a non-significant trend in aluminum con-
centration from the inner core of the tumors to the periph-
eral areas. Speculatively, this trend may be attributable to
the preferential accumulation of aluminum due to the bio-
chemistry of tumorous tissues, as previously hypothesized
by Mannello [21]. It is also sensible to infer that the outer
regions of the tumor may concentrate higher quantities of
aluminum due to uptake by the immune system from the
axillary skin.
We found a significant association between age and
menopausal status with aluminum concentration in the
central and peripheral regions of the tumors. This may
be attributable to the time effect of continual usage of
aluminum-based antiperspirants, or to other exposures.
However, this finding has never been reported before for
breast tissues, although other studies using nipple aspir-
ate fluids from women with breast cancer have shown
higher aluminum levels in post-menopausal subjects.
Also, it has been suggested that age might be related to
aluminum accumulation over time [2,21,22].
Our study had a few possible technical shortcomings. Of
particular concern is the possible interaction between
aluminum and other trace elements, such as calcium. It is
known that the calcium binding protein osteopontin forms
stable complexes with aluminum. It has also been
established that both malignant and nonmalignant breast le-
sions frequently present with microcalcifications, which may
in turn also harbor significant amounts of calcium
[21,23,24]. We did not control our aluminum measurements
for calcium concentrations in the sample, or recorded the
number of radiologically detectable microcalcifications in
the breast lesions. It has also been demonstrated that
aluminum influences the homeostasis of iron binding pro-
teins, in the form of ferritin and transferrin [21].
Conclusion
In conclusion, our study clearly suggests that the
aluminum content of breast tumors may not differ sig-
nificantly from that of the surrounding normal areas of
the breast. In addition, we did not detect significant dif-
ferences in aluminum concentrations as related to the lo-
cation of the breast tumor within the breast, or to other
relevant tumor features such as stage and size. The next
logical step is the assessment of whether or not the
aluminum concentration is related to the key genomic
abnormalities associated with breast carcinogenesis,
which is currently ongoing in our research laboratories.
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